Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Prepaid Assets (2009 - 2025)

Grifols' (GIFLF) quarterly Prepaid Assets came in at $75.7 million in Q4 2025, down 1.66% on a YoY basis from $76.9 million in Q4 2024, and down 1.66% quarter-over-quarter from $76.9 million in Q4 2024.

Analysis

Grifols (GIFLF) Prepaid Assets (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Prepaid Assets for 17 consecutive years, with $75.7 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets fell 1.66% year-over-year to $75.7 million; the trailing twelve-month figure through Dec 2025 stood at $75.7 million (down 1.66% YoY), and the FY2025 full-year result was $73.4 million, down 4.55% from the prior year.
  • Prepaid Assets declined to $75.7 million in Q4 2025 per GIFLF's latest filing, from $76.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $84.4 billion in Q4 2022 and bottomed at $75.7 million in Q4 2025.
  • Historically, Prepaid Assets has averaged $31.6 billion across 5 years, with a median of $79.6 million in 2023.
  • The sharpest annual moves came in 2021 and 2023: Prepaid Assets surged 118706.04% in 2021, then sank 99.91% in 2023.
  • Over 5 years, Prepaid Assets stood at $73.3 billion in 2021, then gained by 15.07% to $84.4 billion in 2022, then tumbled by 99.91% to $79.6 million in 2023, then slipped by 3.29% to $76.9 million in 2024, then slipped by 1.66% to $75.7 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $75.7 million, $76.9 million, and $79.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 75.66 Mn
Dec 31, 2024 76.94 Mn
Dec 31, 2023 79.56 Mn
Dec 31, 2022 84.35 Bn
Dec 31, 2021 73.30 Bn
Dec 31, 2020 61.70 Mn
Sep 30, 2020 51.12 Mn
Mar 31, 2020 50.70 Mn
Dec 31, 2019 64.32 Mn
Sep 30, 2019 81.73 Mn
Mar 31, 2019 24.58 Mn
Dec 31, 2018 48.33 Mn
Sep 30, 2018 74.37 Mn
Jun 30, 2018 42.14 Mn
Mar 31, 2018 37.36 Mn
Dec 31, 2017 38.09 Mn
Jun 30, 2017 28.72 Mn
Dec 31, 2016 52.18 Mn
Sep 30, 2016 34.73 Mn
Jun 30, 2016 29.34 Mn